Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-02-10 @ 8:35 AM
Study NCT ID:
NCT00083551
Status:
COMPLETED
Last Update Posted:
2015-11-23
First Post:
2004-05-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy
Sponsor:
University of Arkansas
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
5226
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |